Ergocalciferol
Pre-clinicalCompleted 0 views this week 0 watching💤 Quiet
Interest: 20/100
20
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Tuberculosis
Conditions
Tuberculosis
Trial Timeline
Dec 1, 2002 → Sep 1, 2006
NCT ID
NCT00157066About Ergocalciferol
Ergocalciferol is a pre-clinical stage product being developed by Harrow Health for Tuberculosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00157066. Target conditions include Tuberculosis.
What happened to similar drugs?
3 of 5 similar drugs in Tuberculosis were approved
Approved (3) Terminated (1) Active (2)
Hype Score Breakdown
Clinical
3
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00157066 | Pre-clinical | Completed |
Competing Products
20 competing products in Tuberculosis